Lexington Biosciences Introduces President and Board Chair
VANCOUVER, BC — (Marketwired) — 05/23/17 — (CSE: LNB) (LNB.CN) (CNSX: LNB) (the "Company" or "Lexington"), a development-stage medical device company operating within the healthcare industry, is pleased to introduce and welcome Mr. Eric Willis as Company President, and Mr. Doug Janzen as Board Chairman.Mr. Willis is a twenty plus year veteran of the healthcare technology industry with a passion for working closely with clinicians to bring products from concept to market.